One of BIRD’s goal is to improve the clinical and scientific knowledge among IBD professionals and to provide high-quality education in various formats. Please refer to the disclaimer regarding the use of BIRD educational materials.
Click to see the following leaflets: Fatigue - Sexuality - J-pouch - Pregnancy and fertility.
To help patients understand their treatment, we created medication leaflets for the advanced drugs (biologics and small molecules) used in the treatment of IBD (available in both FR and NL):
This patient brochure was created in order to help patients monitor their disease.
Click here to learn more.
This document was creted to help patients better understand the meaning and different types of clinical studies.
This patient brochure was created in order to help patients monitor their disease.
Created in collaboration with:
To help our pediatric patients learn about IBD in a playful and informative way, we collaborated with IBD pediatricians, IBD (pediatric) nurses, IBD gastroenterologists, IBD patient organizations and our partner AMGEN to create this colorful pediatric IBD booklet.
You can download the booklet here:
In collaboration with our partner 
To request physical copies of this booklet, please contact our Amgen colleagues: Jan Van Baeveghem (jvanbaev@amgen.com) or Vincent De Cleer (vdecleer@amgen.com).
This one-page, patient-oriented leaflet was designed to promote understanding and awareness of clinical studies.
It provides a clear overview of what participation entails and outlines the various types of clinical studies in an accessible format.
Download this flyer here (in NL, FR and EN)
Measurement of fecal calprotectin is often used to monitor intestinal inflammation in patients with IBD. BIRD developed the calpro card, with information and practical tips for patients on how to collect a stool sample for fecal calprotectin measurement. In collaboration with BINAstoria and our partner Abbvie.
The Calpro card can be dowloaded here:
In collaboration with our partner 
To order the calpro card for your patients, contact:
Hanne Van Spaendonk (hanne.vanspaendonk@abbvie.com)
Medical Science Liaison Gastroenterology
BIRD set up a 3-round Delphi process in order to come to a set of statements regarding the practical use of subcutaneous infliximab and vedolizumab. Participants included not only 45 IBD physicians, but also 16 IBD patients and 9 IBD nurses. The key findings of the DIAMOND exercise and the practical guidelines to implement SC therapy in your daily practice, are explained by the leading experts, in a series of videos (NL, FR, EN). Click here to watch.
